GRB2 and non-small cell lung carcinoma: Our data suggest that the results are robust in different NSCLC datasets and the key target genes identified (ITGA2B, FLNA, GRB2, FCGR2A, and APP, etc.)seem to also be strongly expressed in the breast cancer and pancreatic cancer datasets we analyzed.